Thursday, March 07, 2013 5:30 pm
News Summary: Merck names ex-Amgen exec to run R&D
By The Associated Press
TRANSITION GAME: Perlmutter, 60, will work for a time with current research head Peter Kim, 55. Kim is to leave Merck on Aug. 1 after a decade in the job.
PRODUCTIVE STRETCH: Perlmutter ran Amgen Inc.'s research from 2001 through February 2012. Over that stretch, he oversaw development of several pills and biologic drugs for conditions including cancer, endocrine and blood disorders, osteoporosis and inflammation.